Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
29
NCT04581785
Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 29, 2021
Completion: Jan 10, 2023
NCT05821777
A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors
Role: Collaborator
Start: Mar 28, 2023
Completion: Sep 9, 2025